The ability to specifically silence genes using siRNA has enormous potential for treating genetic diseases. However, siRNA instability and biodistribution issues still need to be overcome, and adequate delivery vehicles have proven indispensable in conveying siRNA to its target. Chitosan is a promising biopolymer for siRNA delivery, its interest stemming from its safety, biodegradability, mucoadhesivity, permeation enhancing effect and cationic charge, as well as amenability to undergo chemical modifications. Chitosan and its derivatives can be readily arranged into complexes or nanoparticles able to entrap and carry siRNA. Specific strategies have been adopted to improve chitosan-based vectors with regard to transfectability. However, furt...
RNA interference (RNAi) using small interfering RNA (siRNA) might provide a way to silence disease-a...
The ability to specifically silence genes by RNA interference has an enormous potential for treating...
Non-viral gene delivery vectors have lagged far behind viral ones in the current pipeline of clinica...
The ability to specifically silence genes using siRNA has enormous potential for treating genetic di...
The use of RNA interference mechanism and small interfering RNA (siRNA) in cancer gene therapy is a ...
Natural polysaccharides are frequently used in the design of drug delivery systems due to their bioc...
In recent years biopharmaceutical companies have started to turn their attention towards small inter...
The mechanism of RNA silencing has first been evidenced in plants. Then, studies on the nematode Cae...
Gene therapy is an emerging and promising strategy in cancer therapy where small interfering RNA (si...
Gene therapy is promising for the treatment of many currently incurable diseases by delivering or si...
Non-viral gene delivery vectors have lagged far behind viral ones in the current pipeline of clinica...
peer reviewedThis study aims at developing chitosan-based nanoparticles suitable for an intravenous ...
RNA interference, the process in which small interfering RNAs (SiRNAs) silence a specific gene and t...
The use of the biomaterial chitosan (CS) to form CS/siRNA nanoparticles for gene silencing have been...
SUMMARY: Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for t...
RNA interference (RNAi) using small interfering RNA (siRNA) might provide a way to silence disease-a...
The ability to specifically silence genes by RNA interference has an enormous potential for treating...
Non-viral gene delivery vectors have lagged far behind viral ones in the current pipeline of clinica...
The ability to specifically silence genes using siRNA has enormous potential for treating genetic di...
The use of RNA interference mechanism and small interfering RNA (siRNA) in cancer gene therapy is a ...
Natural polysaccharides are frequently used in the design of drug delivery systems due to their bioc...
In recent years biopharmaceutical companies have started to turn their attention towards small inter...
The mechanism of RNA silencing has first been evidenced in plants. Then, studies on the nematode Cae...
Gene therapy is an emerging and promising strategy in cancer therapy where small interfering RNA (si...
Gene therapy is promising for the treatment of many currently incurable diseases by delivering or si...
Non-viral gene delivery vectors have lagged far behind viral ones in the current pipeline of clinica...
peer reviewedThis study aims at developing chitosan-based nanoparticles suitable for an intravenous ...
RNA interference, the process in which small interfering RNAs (SiRNAs) silence a specific gene and t...
The use of the biomaterial chitosan (CS) to form CS/siRNA nanoparticles for gene silencing have been...
SUMMARY: Small interfering RNA (siRNA) has been widely investigated as a potential therapeutic for t...
RNA interference (RNAi) using small interfering RNA (siRNA) might provide a way to silence disease-a...
The ability to specifically silence genes by RNA interference has an enormous potential for treating...
Non-viral gene delivery vectors have lagged far behind viral ones in the current pipeline of clinica...